Mr. Campanelli has served as Malvern, Pa.-based Endo’s CEO since 2016 and will continue in his role until a new CEO is named. He has also been appointed as chairman of the board, effective immediately.
Roger Kimmel, the previous chairman of the board, will become the senior independent director. He replaces Sharad Mansukar, who is resigning to become a chairman of investment firm TPG Partners.
Read the full article here.
More articles on pharmacy:
Amgen exits neuroscience research, cuts 180 US jobs
Walgreens’ exit from health clinic business should serve as a warning to rivals
Top 10 pharmacy stories in October